Why the study?
Does low-molecular-weight heparin prevent bleeding or thromboembolic complications in patients with mechanical circulatory support and intracranial hemorrhage?
Does low-molecular-weight heparin prevent bleeding or thromboembolic complications in patients with mechanical circulatory support and intracranial hemorrhage?
Low-molecular-weight heparin may be a safe option for managing anticoagulation in patients with mechanical circulatory support who develop intracranial hemorrhage.
Patients on mechanical circulatory support are at high risk of bleeding, particularly intracranial hemorrhage (ICH). The management of ICH in patients needing anticoagulation and antiplatelet therapies remains a challenge. We report our initial experience of ICH management with low-molecular-weight heparin in patients with mechanical circulatory support, without bleeding or thromboembolic complications.
No takes yet. Share an insight, caveat, or question.
Vermès et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: